The global liver cancer diagnostics market was valued at US$ 9.6 billion in 2024 and is projected to reach US$ 18.4 billion by 2035, driven by the rising prevalence of liver cancer and growing demand for early detection technologies. The market is anticipated to expand at a CAGR of 6.1% from 2025 to 2035, supported by advancements in imaging techniques, biomarker testing, and increasing...